期刊文献+

应用Ion Torrent半导体测序检测马凡综合征患者FBN1基因致病突变 被引量:3

Mutation detection of FBN1 in marfan syndrome patients by Ion Torrent semi-conductor sequencing
下载PDF
导出
摘要 目的:对3个马凡综合征(MFS)家系及1例MFS患者的原纤维蛋白1基因(FBN1)进行基因检测,以明确致病突变,为患者提供遗传咨询及产前诊断。方法:应用高通量Ion Torrent半导体测序技术对3个MFS家系的先证者及1例MFS患者的FBN1基因进行检测,筛选致病突变位点,并用Sanger测序法验证。对1例胎儿FBN1基因相应的位点进行检测,以明确其受累情况。结果:患者P1 FBN1基因检测到c.7125_7126 del TG杂合性缺失突变,为可疑致病位点;家系1患者FBN1基因检测到IVS 27-1G>C(c.3464-1G>C)杂合性突变,为致病突变;家系2患者FBN1基因检测到c.4981G>C(p.Gly1661Arg)杂合性错义突变,为致病突变,胎儿携带同样突变;家系3患者FBN1基因检测到c.1546C>T(p.Arg516Term)杂合性无义突变,为致病突变。结论:应用高通量Ion Torrent半导体测序技术检测到3个MFS家系及1个MFS患者的致病基因突变,为临床诊断及遗传咨询提供分子遗传学依据,并对1例胎儿进行了产前诊断。 Objective:To identify pathogenic mutations of FBN1 in 3 Marfan syndrome (MFS) families and 1 MFS patient for genetic counseling and prenatal diagnosis. Methods:U- sing Ion Torrent semi-conductor sequencing to detect mutations of FBN1 in 3 Marfan syndrome (MFS) families and 1 MFS patient, then select pathogenic mutations, using Sanger sequencing to verify these mutations. Using Sanger sequencing to detect the corresponding site of FBN1 in the fetus. Results:we identified one probably pathogenic FBN1 mutation( c. 7125_7126 del TG) in patient P1, one pathogenic FBN1 mutation( IVS 27-1G〉C) in patients of family 1, one pathogenic FBN1 mutation( c. 4981G〉C) in patient P6 and the fetus of family 2 ,one pathogen- ic FBN1 mutation( c. 1546C〉T) in patients of family 3. Conclusion:We indentified pathogenic FBN1 mutations in 3 Marfan syndrome(MFS) families and 1 MFS patient, provided molecular genetic evidences for clinical diagnosis and genetic counseling, and made a prenatal diagnosis in one fetus.
出处 《现代妇产科进展》 CSCD 北大核心 2015年第3期201-204,共4页 Progress in Obstetrics and Gynecology
基金 南京市卫生青年人才培养工程(No:QRX11337)
关键词 ION Torrent半导体测序技术 马凡综合征 FBN1基因 Ion Torrent semi-conductor sequencing Marfan syndrome FBN1
  • 相关文献

参考文献8

  • 1Dietz HC,Cutting GR,Pyeritz RE,et al.Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene[J].Nature,1991,352(6333):337-339.
  • 2Loeys B,De Backer J,Van Acker P,et al.Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome[J].Hum Mutat,2004,24(2):140-146.
  • 3De Paepe A,Devereux RB,Dietz HC,et al.Revised diagnostic criteria for the Marfan syndrome[J].Am J Med Genet,1996,62(4):417-426.
  • 4Stheneur C,Collod-Beroud G,Faivre L,et al.Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene[J].Eur J Hum Genet,2009,17(9):1121-1128.
  • 5Khau Van Kien P,Baux D,Pallares-Ruiz N,et al.Missense mutations of conserved glycine residues in fibrillin-1highlight a potential subtype of cb-EGF-like domains.Hum Mutat,2010,31(1):E1021-1042.
  • 6Magyar I,Colman D,Arnold E,et al.Quantitative sequence analysis of FBN1 premature termination codons provides evidence for incomplete NMD in leukocytes[J].Hum Mutat,2009,30(9):1355-1364.
  • 7Arbustini E,Grasso M,Ansaldi S,et al.Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies[J].Hum Mutat,2005,26(5):494.
  • 8Aalberts JJ,van Tintelen JP,Meijboom LJ,et al.Relation between genotype and left-ventricular dilatation in patients with Marfan syndrome[J].Gene,2014,534(1):40-43.

同被引文献32

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部